vs
Side-by-side financial comparison of PEGASYSTEMS INC (PEGA) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $430.0M, roughly 1.4× PEGASYSTEMS INC). Royalty Pharma plc runs the higher net margin — 34.4% vs 7.6%, a 26.8% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -9.6%). Over the past eight quarters, PEGASYSTEMS INC's revenue compounded faster (10.7% CAGR vs 4.6%).
Pegasystems Inc. (Pega) is a global software company based in Waltham, Massachusetts, in the United States, and founded in 1983. The company has been publicly traded since 1996 as PEGA (NASDAQ). Pega is a low-code platform for workflow automation and generative AI-powered decision-making for businesses.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
PEGA vs RPRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $430.0M | $622.0M |
| Net Profit | $32.8M | $214.2M |
| Gross Margin | 75.2% | — |
| Operating Margin | 8.6% | 62.4% |
| Net Margin | 7.6% | 34.4% |
| Revenue YoY | -9.6% | 4.8% |
| Net Profit YoY | — | 2.9% |
| EPS (diluted) | $0.18 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $430.0M | — | ||
| Q4 25 | $504.3M | $622.0M | ||
| Q3 25 | $381.4M | $609.3M | ||
| Q2 25 | $384.5M | $578.7M | ||
| Q1 25 | $475.6M | $568.2M | ||
| Q4 24 | $490.8M | $593.6M | ||
| Q3 24 | $325.1M | $564.7M | ||
| Q2 24 | $351.2M | $537.3M |
| Q1 26 | $32.8M | — | ||
| Q4 25 | $234.6M | $214.2M | ||
| Q3 25 | $43.4M | $288.2M | ||
| Q2 25 | $30.1M | $30.2M | ||
| Q1 25 | $85.4M | $238.3M | ||
| Q4 24 | $119.1M | $208.2M | ||
| Q3 24 | $-14.4M | $544.0M | ||
| Q2 24 | $6.6M | $102.0M |
| Q1 26 | 75.2% | — | ||
| Q4 25 | 79.5% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 71.5% | — | ||
| Q1 25 | 78.5% | — | ||
| Q4 24 | 79.1% | — | ||
| Q3 24 | 70.2% | — | ||
| Q2 24 | 72.4% | — |
| Q1 26 | 8.6% | — | ||
| Q4 25 | 20.7% | 62.4% | ||
| Q3 25 | 3.8% | 70.1% | ||
| Q2 25 | 4.5% | 36.3% | ||
| Q1 25 | 26.7% | 94.0% | ||
| Q4 24 | 29.1% | 60.9% | ||
| Q3 24 | -3.6% | — | ||
| Q2 24 | 3.7% | 50.2% |
| Q1 26 | 7.6% | — | ||
| Q4 25 | 46.5% | 34.4% | ||
| Q3 25 | 11.4% | 47.3% | ||
| Q2 25 | 7.8% | 5.2% | ||
| Q1 25 | 18.0% | 41.9% | ||
| Q4 24 | 24.3% | 35.1% | ||
| Q3 24 | -4.4% | 96.3% | ||
| Q2 24 | 1.9% | 19.0% |
| Q1 26 | $0.18 | — | ||
| Q4 25 | $0.81 | $0.49 | ||
| Q3 25 | $0.24 | $0.67 | ||
| Q2 25 | $0.17 | $0.07 | ||
| Q1 25 | $0.91 | $0.55 | ||
| Q4 24 | $1.35 | $0.46 | ||
| Q3 24 | $-0.17 | $1.21 | ||
| Q2 24 | $0.07 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $270.0M | $618.7M |
| Total DebtLower is stronger | — | $9.0B |
| Stockholders' EquityBook value | $705.9M | $9.7B |
| Total Assets | $1.6B | $19.6B |
| Debt / EquityLower = less leverage | — | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $270.0M | — | ||
| Q4 25 | $425.8M | $618.7M | ||
| Q3 25 | $351.4M | $938.9M | ||
| Q2 25 | $411.6M | $631.9M | ||
| Q1 25 | $371.7M | $1.1B | ||
| Q4 24 | $740.0M | $929.0M | ||
| Q3 24 | $703.0M | $950.1M | ||
| Q2 24 | $665.1M | $1.8B |
| Q1 26 | — | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B |
| Q1 26 | $705.9M | — | ||
| Q4 25 | $787.4M | $9.7B | ||
| Q3 25 | $596.8M | $9.6B | ||
| Q2 25 | $624.5M | $9.5B | ||
| Q1 25 | $611.3M | $9.8B | ||
| Q4 24 | $585.5M | $10.3B | ||
| Q3 24 | $473.0M | $10.3B | ||
| Q2 24 | $435.4M | $9.8B |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $19.6B | ||
| Q3 25 | $1.3B | $19.3B | ||
| Q2 25 | $1.3B | $18.3B | ||
| Q1 25 | $1.3B | $17.6B | ||
| Q4 24 | $1.8B | $18.2B | ||
| Q3 24 | $1.6B | $18.0B | ||
| Q2 24 | $1.5B | $17.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $827.1M |
| Free Cash FlowOCF − Capex | $206.5M | — |
| FCF MarginFCF / Revenue | 48.0% | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $494.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $158.4M | $827.1M | ||
| Q3 25 | $56.3M | $702.6M | ||
| Q2 25 | $86.3M | $364.0M | ||
| Q1 25 | $204.2M | $596.1M | ||
| Q4 24 | $95.2M | $742.5M | ||
| Q3 24 | $30.5M | $703.6M | ||
| Q2 24 | $40.1M | $658.2M |
| Q1 26 | $206.5M | — | ||
| Q4 25 | $152.4M | — | ||
| Q3 25 | $51.8M | — | ||
| Q2 25 | $84.1M | — | ||
| Q1 25 | $202.3M | — | ||
| Q4 24 | $92.4M | — | ||
| Q3 24 | $27.4M | — | ||
| Q2 24 | $38.8M | — |
| Q1 26 | 48.0% | — | ||
| Q4 25 | 30.2% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 21.9% | — | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | 18.8% | — | ||
| Q3 24 | 8.4% | — | ||
| Q2 24 | 11.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.68× | 3.86× | ||
| Q3 25 | 1.30× | 2.44× | ||
| Q2 25 | 2.87× | 12.06× | ||
| Q1 25 | 2.39× | 2.50× | ||
| Q4 24 | 0.80× | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | 6.06× | 6.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PEGA
| Pega Cloud | $205.0M | 48% |
| Subscription license | $94.9M | 22% |
| Maintenance | $75.3M | 18% |
| Consulting | $54.8M | 13% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
